Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer

clinical trial

Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT00303628

P6099clinical trial phasephase III clinical trialQ42824827
P17countryUnited States of AmericaQ30
CanadaQ16
PeruQ419
P582end time2015-04-01
P131located in the administrative territorial entityPuerto RicoQ1183
P1050medical conditionadenocarcinomaQ356033
P2899minimum age18
P1132number of participants355
P4844research interventioncalcium oxalateQ412399
bevacizumabQ413299
fluorouracilQ238512
immunological antineoplastic agentQ50429626
leucovorin calciumQ27077063
P6153research siteVanderbilt UniversityQ29052
Cornell UniversityQ49115
University of Southern CaliforniaQ4614
New York UniversityQ49210
University of California, DavisQ129421
University of ChicagoQ131252
University of RochesterQ149990
University of CincinnatiQ153265
University of TorontoQ180865
University of PennsylvaniaQ49117
Northwestern UniversityQ309350
University of VirginiaQ213439
University of PittsburghQ235034
Rutgers UniversityQ499451
Saint Louis UniversityQ734774
Georgetown UniversityQ333886
University of MiamiQ738258
Creighton UniversityQ770544
Case Western Reserve UniversityQ1047060
Rush University Medical CenterQ1535116
Kaiser PermanenteQ1721601
University of Hawaiʻi at HiloQ2150914
University of ToledoQ2302319
Yeshiva UniversityQ1048851
Mayo ClinicQ1130172
Columbia University Irving Medical CenterQ2415975
AdventHealth PorterQ3145247
Cleveland ClinicQ4117596
Allegheny General HospitalQ4731305
Bryn Mawr HospitalQ4980899
California Pacific Medical CenterQ5020739
Cross Cancer InstituteQ5188247
Eastern Cooperative Oncology GroupQ5330089
Eastern Maine Medical CenterQ5330270
Fox Chase Cancer CenterQ5476635
Augusta UniversityQ5547686
Grady Memorial HospitalQ5592136
Hennepin County Medical CenterQ5714832
Highland HospitalQ5758843
Intermountain HealthQ6047563
Intermountain Medical CenterQ6047575
Lehigh Valley HospitalQ6518847
Loyola University Medical CenterQ6694611
Atrium Health Navicent The Medical CenterQ6806287
Memorial Medical CenterQ6815474
Monmouth Medical CenterQ6901093
Billings Clinic CodyQ50036507
Freeman Health SystemQ50039515
Elkhart General HospitalQ87932226
Montefiore Medical CenterQ6905066
Morristown Medical CenterQ6914126
Munson Medical CenterQ6936903
Newark Beth Israel Medical CenterQ7016630
Piedmont HospitalQ7191520
Roswell Park Comprehensive Cancer CenterQ7370121
Swedish Medical CenterQ7654755
Texas Tech University Health Sciences Center Amarillo CampusQ7708146
The Christ HospitalQ7722703
University Medical Center of Southern NevadaQ7894830
University of Nebraska Medical CenterQ7895888
University of Oklahoma Health Sciences CenterQ7896014
Washington Hospital CenterQ7971940
Washington University School of MedicineQ7972509
Hurley Medical CenterQ14716149
Carolinas Medical CenterQ17514683
Decatur Memorial HospitalQ22033932
Memorial Health University Medical CenterQ30253539
MetroHealth Medical CenterQ30254005
UNM Los LunasQ30258334
Sky Ridge Medical CenterQ30270451
Aultman Health FoundationQ30279875
Iowa Methodist Medical CenterQ30280192
Providence HospitalQ30280436
Via Christi Regional Medical CenterQ30281040
Mercy Medical CenterQ30281132
Jupiter Medical CenterQ30288257
University of Vermont Children’s HospitalQ30289331
University of Kansas Medical CenterQ33526980
P580start time2006-02-01
P8363study typeinterventional studyQ78089383
P1476titleIntergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5-Fluorouracil and Leucovorin vs Oxaliplatin, 5-Fluorouracil, Leucovorin and Bevacizumab for Patients With Stage II or III Rectal Cancer Receiving Pre-operative Chemoradiation